SCHEMBL7992177

SCHEMBL7992177

Oc1nc(-c2ccccn2)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.42
HTT P42858 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
GLA P06280 1/20 0.42
UBE2N P61088 1/20 0.42
HIF1A Q16665 1/20 0.41
ACP1 P24666 1/20 0.40
GRM5 P41594 2/20 0.40
HTR6 P50406 2/20 0.39
YTHDC1 Q96MU7 3/20 0.39
FFAR1 O14842 1/20 0.39
NPC1 O15118 2/20 0.39
MAPT P10636 2/20 0.39
MITF O75030 1/20 0.39
TP53 P04637 1/20 0.39
PKM P14618 1/20 0.39
TSHR P16473 1/20 0.39
RAB9A P51151 1/20 0.39
LMNA P02545 1/20 0.39
PPP1CA P62136 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985492 0.90 SMN1; SMN2 (0.42) SMN1; SMN2HIF1ANPC1TP53RAB9A
SCHEMBL7991788 0.87 CYP11B1 (0.46) SMN1; SMN2HTTL3MBTL1HIF1AGRM5
SCHEMBL7974007 0.87 KDM4C (0.41) GRM5FFAR1NPC1RAB9ALMNA
SCHEMBL7988668 0.86 SMN1; SMN2 (0.44) SMN1; SMN2HTTL3MBTL1GLAUBE2N
SCHEMBL7985456 0.85 GAA (0.48) SMN1; SMN2HIF1AGRM5YTHDC1FFAR1
SCHEMBL7973626 0.84 SMN1; SMN2 (0.45) SMN1; SMN2HTTL3MBTL1GLAUBE2N
SCHEMBL7984878 0.84 MAPK14 (0.42) SMN1; SMN2HTTL3MBTL1GLAUBE2N
SCHEMBL7974267 0.84 SMN1; SMN2 (0.43) SMN1; SMN2HTTL3MBTL1GLAUBE2N
SCHEMBL7991532 0.84 SMN1; SMN2 (0.43) SMN1; SMN2HTTL3MBTL1HIF1ANPC1
SCHEMBL7974053 0.84 MET (0.44) GLAFFAR1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed